Welcome to Fierce Biotech’s fifth annual layoff tracker, a resource designed to keep pace with the sector’s steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...

GLP-1 drugs challenge traditional pricing frameworks by combining chronic use, very large patient populations, and high manufacturing complexity. Here, we delve behind recent headline list prices, ...